Bio-Rad Laboratories (NYSE:BIO) Earnings Information
Bio-Rad Laboratories last issued its earnings data on October 31st, 2019. The medical research company reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.25. The firm had revenue of $560.60 million for the quarter, compared to analysts' expectations of $561.40 million. Its revenue was up 2.8% compared to the same quarter last year. Bio-Rad Laboratories has generated $5.84 earnings per share over the last year and currently has a price-to-earnings ratio of 62.3. Bio-Rad Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2020 based off prior year's report dates.
Bio-Rad Laboratories Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Bio-Rad Laboratories (NYSE:BIO) Earnings Estimates
2019 EPS Consensus Estimate: $7.40
2020 EPS Consensus Estimate: $9.33
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2019 | 1 | $1.76 | $1.76 | $1.76 |
| Q2 2019 | 1 | $1.22 | $1.22 | $1.22 |
| Q3 2019 | 1 | $1.77 | $1.77 | $1.77 |
| Q4 2019 | 1 | $2.65 | $2.65 | $2.65 |
| Q1 2020 | 1 | $2.04 | $2.04 | $2.04 |
| Q2 2020 | 1 | $2.52 | $2.52 | $2.52 |
| Q3 2020 | 1 | $2.23 | $2.23 | $2.23 |
| Q4 2020 | 1 | $2.54 | $2.54 | $2.54 |
Bio-Rad Laboratories (NYSE BIO) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | GAAP EPS | Revenue Estimate | Actual Revenue | Conference Call | Details |
|---|
2/27/2020
(Estimated) | | | | | | | | |
| 10/31/2019 | Q3 | $1.36 | $1.61 | $11.90 | $561.40 million | $560.60 million | Transcript | |
| 8/1/2019 | Q2 2019 | $1.39 | $1.57 | ($16.72) | $564.88 million | $572.60 million | Listen | |
| 5/8/2019 | 3/31/2019 | $1.12 | $1.65 | ($25.44) | $548.82 million | $553.98 million | Listen | |
| 2/28/2019 | Q4 2018 | $1.61 | $2.13 | $32.14 | $610.65 million | $617.54 million | N/A | |
| 11/1/2018 | 9/30/2018 | $1.16 | $0.91 | ($7.07) | $541.23 million | $545.10 million | Transcript | |
| 8/7/2018 | Q2 2018 | $1.27 | $1.64 | ($5.59) | $551.05 million | $575.91 million | N/A | |
| 5/8/2018 | Q1 2018 | $1.07 | $1.17 | ($19.43) | $527.20 million | $551.52 million | N/A | |
| 2/27/2018 | Q4 2017 | $1.28 | $1.50 | $0.68 | $618.89 million | $620.43 million | N/A | |
| 11/2/2017 | Q3 2017 | $0.54 | $0.91 | $0.91 | $507.99 million | $535.00 million | N/A | |
| 8/3/2017 | Q2 2017 | $0.63 | $0.58 | $0.99 | $515.04 million | $504.67 million | N/A | |
| 5/4/2017 | Q1 2017 | $0.27 | $0.41 | $0.41 | $477.76 million | $500.05 million | Listen | |
| 2/23/2017 | Q416 | $1.03 | ($0.70) | $3.20 | $574.40 million | $571.45 million | N/A | |
| 11/1/2016 | Q316 | $0.51 | $0.62 | $0.62 | $480.60 million | $508.75 million | N/A | |
| 8/3/2016 | Q2 | $1.13 | $0.61 | $0.61 | $497.80 million | $516.80 million | N/A | |
| 5/5/2016 | Q1 | $0.60 | $0.42 | $0.42 | $463.90 million | $471.20 million | N/A | |
| 2/25/2016 | Q415 | $1.27 | $1.68 | $1.68 | $570.80 million | $570.56 million | Listen | |
| 11/3/2015 | Q315 | $0.54 | $0.59 | $0.59 | $495.55 million | $469.96 million | N/A | |
| 8/6/2015 | Q215 | $0.78 | $0.97 | $0.97 | $494.85 million | $506.10 million | N/A | |
| 5/5/2015 | Q115 | $0.33 | $0.61 | $0.61 | $474.60 million | $472.80 million | N/A | |
| 2/26/2015 | Q414 | $1.18 | $1.34 | $1.34 | $593.41 million | $598.20 million | N/A | |
| 11/4/2014 | Q314 | $0.86 | $0.39 | $0.39 | $525.40 million | $530.64 million | N/A | |
| 8/5/2014 | Q214 | $0.95 | $1.09 | $1.09 | $537.58 million | $536.80 million | Transcript | |
| 5/6/2014 | Q114 | $0.80 | $0.23 | $0.23 | $515.00 million | $509.30 million | N/A | |
| 2/27/2014 | Q413 | $1.42 | $1.04 | | $586.67 million | $602.60 million | Listen | |
| 11/8/2013 | Q3 2013 | $0.66 | $0.56 | $1.37 | $529.02 million | $505.10 million | Listen | |
| 8/6/2013 | Q2 2013 | $1.12 | $1.20 | $1.20 | $532.60 million | $525.30 million | Listen | |
| 5/7/2013 | Q1 2013 | $1.10 | $0.68 | $0.68 | $506.34 million | $499.70 million | N/A | |
| 2/26/2013 | Q4 2012 | $1.33 | $1.65 | | $558.68 million | $573.80 million | Transcript | |
| 11/6/2012 | Q312 | $1.14 | $1.48 | | $507.79 million | $498.70 million | N/A | |
| 8/7/2012 | | $1.19 | $1.69 | | | | N/A | |
| 5/1/2012 | | $1.02 | $1.09 | | | | Transcript | |
| 2/23/2012 | | $1.67 | $2.08 | | | | N/A | |
| 11/1/2011 | | $1.53 | $1.61 | | | | N/A | |
| 8/2/2011 | | $1.47 | $1.41 | | | | N/A | |
| 5/3/2011 | | $1.32 | $1.16 | | | | N/A | |
| 2/24/2011 | | $1.35 | $2.41 | | | | N/A | |
| 11/2/2010 | Q3 2010 | $1.17 | $1.59 | $1.59 | | | N/A | |
| 8/3/2010 | Q2 2010 | $1.27 | $1.35 | $1.35 | | | N/A | |
| 5/4/2010 | Q1 2010 | $1.17 | $1.24 | $1.24 | | | N/A | |
| 2/24/2010 | Q4 2009 | $1.08 | $1.49 | $1.63 | | | N/A | |
| 11/3/2009 | Q3 2009 | $1.00 | $1.38 | $1.38 | | | N/A | |
| 8/4/2009 | Q2 2009 | $1.03 | $1.37 | $1.37 | | | N/A | |
| 5/5/2009 | Q1 2009 | $0.98 | $1.10 | $1.10 | | | N/A | |
| 2/26/2009 | Q4 2008 | $0.90 | $1.18 | $2.66 | | | N/A | |
| 11/6/2008 | Q3 2008 | $1.06 | $1.01 | $1.01 | | | N/A | |
| 8/5/2008 | Q2 2008 | $1.08 | $1.58 | $1.58 | | | N/A | |
| 5/6/2008 | Q1 2008 | $0.99 | $0.97 | $0.97 | | | N/A | |
| 2/28/2008 | Q4 2007 | $0.80 | $0.92 | $1.39 | | | N/A | |
(Earnings results data provided by Zacks Investment Research)
